Cytokine discovered by NFCR Fellow Paul Fisher holds promise for combating prostate cancer bone metastasis
Published study continues to build evidence that cytokine discovered by NFCR Fellow Paul Fisher holds promise for combating prostate cancer bone metastasis
Worldwide burden of cancer attributable to diabetes and high body-mass index
The International Agency for Research on Cancer (IARC) and the World Cancer Research Fund (WCRF) have concluded that there is a causal association between diabetes and high BMI and several types of cancer. As the prevalence of these cancer risk factors…
Quartet of NFCR Scientists Publishes Papers in Immediate Succession
FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations …
A new study on Gliblastoma supported by NFCR just published
In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes,…
Two National Foundation for Cancer Research Scientists Among the National Academy of Inventors’ Latest Class
FOR IMMEDIATE RELEASE: April 5, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Honor Recognizes Top Academic Inventors BETHESDA, MD – In an event this afternoon at the historic Mayflower Hotel…
Duo of Oncology Vaccine Pioneers at the National Cancer Institute to Receive 2018 Annual Szent-Györgyi Prize for Progress in Cancer Research
FOR IMMEDIATE RELEASE: February 15, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org First Occasion for Award to Recognize Extraordinary Contributions in Cancer Prevention, Role of Vaccines BETHESDA, MD – The National Foundation for…
Attacking Metastatic Tumors in the Brain
Targeting HER3 could cripple metastatic cancers that have spread to the brain. (Bethesda, MD, June 5, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National…
Mary-Claire King, @UW 2016 Szent-Györgyi Prize
WASHINGTON, DC. NATIONAL PRESS CLUB. May 2, 2016 6pm The National Press Club was the setting for the award ceremony recognizing Mary-Claire King, Ph.D., University of Washington professor of medicine and genome sciences as the 2016 recipient of the Szent-Györgyi Prize for…
2016 Szent-Györgyi Prize for Progress in Cancer Research
Mary-Claire King, Ph.D. of University of Washington Awarded 2016 Szent-Györgyi Prize for Progress in Cancer Research (Bethesda, MD – January 21, 2016) The National Foundation forCancer Research (NFCR) announced today that Mary-Claire King, Ph.D., University of Washington professor of medicine (medical…
Free Cancer Screening Guidelines
